Sanofi (SNYNF) Equity Average (2018)

Sanofi's (SNYNF) quarterly Equity Average came in at $70.0 billion in Q1 2018.

Sanofi (SNYNF) Equity Average (2018) Analysis & Trends

Sanofi has disclosed Equity Average across 1 years of filings, most recently posting $70.0 billion for Q1 2018.

Equity Average for Q1 2018 came in at $70.0 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2018 was $70.0 billion (changed N/A YoY), and the FY2025 annual result was $83.0 billion, up 1.84% from the prior year.
Equity Average came in at $70.0 billion for Q1 2018 at Sanofi.
In the past five years, Equity Average ranged from a high of $70.0 billion in Q1 2018 to a low of $70.0 billion in Q1 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Avg. (Qtr)
1	Gsk	96,436,181.12 Bn	96,436,176.16 Bn	7.76 Bn	-
2	Eli Lilly	1,017.30 Bn	1,012.01 Bn	16.22 Bn	28.87 Bn
3	Johnson & Johnson	579.61 Bn	557.55 Bn	15.96 Bn	81.37 Bn
4	AbbVie	402.30 Bn	392.96 Bn	10.78 Bn	-4.96 Bn
5	Merck	294.24 Bn	288.59 Bn	12.09 Bn	49.27 Bn
6	Amgen	191.82 Bn	179.78 Bn	5.87 Bn	8.92 Bn
7	Gilead Sciences	155.93 Bn	148.21 Bn	5.52 Bn	23.11 Bn
8	Pfizer	149.05 Bn	136.28 Bn	-1.21 Bn	88.29 Bn
9	Bristol Myers Squibb	116.33 Bn	105.88 Bn	8.07 Bn	19.27 Bn
10	Sanofi	-	-	9.49 Bn	-

Historic Data

Download Data

Date	Value
Mar 31, 2018	69.97 Bn